遺伝子編集の世界市場レポート 2025

遺伝子編集市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR19.1％で207億9,000万米ドルに成長します。予測期間の成長は、治療用途の拡大、精密性と効率性の向上、遺伝子治療の商業化、農業用途の開発、再生医療の成長に起因すると考えられます。予測期間の主な動向には、多重編集技術、塩基編集イノベーション、遺伝子ドライブと集団改変、非ウイルスデリバリーシステム、疾患モデリングと創薬が含まれます。

伝染性疾患の有病率の上昇が遺伝子編集市場の成長を促進しており、遺伝子編集技術はこれらの疾患の検出と治療に不可欠となっています。伝染病は、細菌、ウイルス、寄生虫などの感染因子に起因するもので、人や動物の間で、あるいは環境への暴露によって広がる可能性があります。遺伝子編集テクノロジーは、遺伝子レベルで病原体を特定し中和するための標的メソッドを開発するためにますます使用されるようになり、その結果、疾病管理と予防が強化されます。例えば2023年、スイスを拠点とする国際的な非政府組織である世界経済フォーラムは、パンデミック以降、インフルエンザや呼吸器合胞体ウイルス（RSV）などの感染症が増加していると報告しました。米国では2023年2月までに、インフルエンザだけで推定2400万人が罹患し、26万人が入院、1万6000人が死亡しました。さらに2022年、世界保健機関（WHO）は、世界で1,060万人が結核に感染し、130万人が死亡したと報告しました。その結果、伝染病の流行が遺伝子編集市場の成長に拍車をかけています。

世界の遺伝子編集市場は、遺伝性疾患の罹患率の上昇により成長が見込まれています。遺伝性疾患は、個人のDNAに異常や変異が生じるもので、遺伝的なものから自然発生的なものまであります。これらの疾患は、様々な健康問題を引き起こす可能性があり、出生時に存在する場合もあれば、人生の後半に開発される場合もあります。遺伝子編集は、鎌状赤血球症、ハンチントン病、B-サラセミア、嚢胞性線維症、アルツハイマー病、パーキンソン病などの重篤な遺伝性疾患に対処する上で、大きな可能性を秘めています。例えば、米国国立医学図書館（NLM）の報告によると、2023年には65歳以上のアルツハイマー型認知症（AD）を患うアメリカ人は670万人に上ると推定されています。医学的ブレークスルーが介入しない限り、有病率は2060年までに1380万人に増加すると予測されています。遺伝性疾患は増加傾向にあり、遺伝子編集技術の応用が市場成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界遺伝子編集 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の遺伝子編集市場：成長率分析
• 世界の遺伝子編集市場の実績：規模と成長, 2019-2024
• 世界の遺伝子編集市場の予測：規模と成長, 2024-2029, 2034F
• 世界遺伝子編集総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の遺伝子編集市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPR
• TALEN
• ZFN
• 世界の遺伝子編集市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物遺伝子工学
• 植物遺伝子工学
• 細胞株エンジニアリング
• 世界の遺伝子編集市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオテクノロジー
• 製薬
• 契約調査機関
• 世界の遺伝子編集市場、CRISPRのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリスパーCas9
• CRISPR-Cas12
• CRISPR-Cas13
• CRISPRベースの遺伝子ドライブ
• 世界の遺伝子編集市場、TALENのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カスタムTALEN
• 市販のTALENキット
• 世界の遺伝子編集市場、ZFNのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カスタムZFN
• 市販のZFNキット

第7章 地域別・国別分析

• 世界の遺伝子編集市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の遺伝子編集市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 遺伝子編集市場：競合情勢
• 遺伝子編集市場：企業プロファイル
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Life Sciences Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Lonza Group AG
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• CRISPR Therapeutics
• Promega Corporation
• GenScript USA Inc.
• Integrated DNA Technologies Inc.
• Intellia Therapeutics Inc.
• DNA Script Inc.
• Dharmacon Inc.
• Precision Biosciences Inc.
• Editas Medicine Inc.
• OriGene Technologies Inc.
• Tecan Group Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 遺伝子編集市場2029：新たな機会を提供する国
• 遺伝子編集市場2029：新たな機会を提供するセグメント
• 遺伝子編集市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Gene editing refers to the innovative technology enabling precise changes in the genetic code at specific locations within a genome. This cutting-edge process involves manipulating genetic material in various fields such as cell line engineering, animal genetic engineering, and plant genetic engineering.

The primary gene editing technologies include CRISPR, TALEN, and ZFN. CRISPR, a groundbreaking method, empowers geneticists and medical researchers to edit sections of the genome by altering, inserting, or removing DNA sequences accurately. These technologies find applications across biotechnology, pharmaceuticals, and contract research organizations, serving purposes in animal genetic engineering, plant genetic engineering, and cell line engineering.

The gene editing market research report is one of a series of new reports from The Business Research Company that provides gene editing market statistics, including gene editing industry global market size, regional shares, competitors with a gene editing market share, detailed gene editing market segments, market trends and opportunities, and any further data you may need to thrive in the gene editing industry. This gene editing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene editing market size has grown rapidly in recent years. It will grow from $8.82 billion in 2024 to $10.34 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to discovery of crispr-cas9, advancements in genetic sequencing, medical breakthroughs, scientific research funding, biotechnology industry growth.

The gene editing market size is expected to see rapid growth in the next few years. It will grow to $20.79 billion in 2029 at a compound annual growth rate (CAGR) of 19.1%. The growth in the forecast period can be attributed to therapeutic applications expansion, precision and efficiency enhancements, gene therapy commercialization, agricultural applications development, regenerative medicine growth. Major trends in the forecast period include multiplex editing techniques, base editing innovations, gene drives and population modification, non-viral delivery systems, disease modeling and drug discovery.

The rising prevalence of communicable diseases is driving growth in the gene editing market, as gene editing techniques become essential for the detection and treatment of these illnesses. Communicable diseases, which result from infectious agents like bacteria, viruses, or parasites, can spread between people, animals, or through environmental exposure. Gene editing technologies are increasingly used to create targeted methods for identifying and neutralizing pathogens at the genetic level, thus enhancing disease management and prevention. For example, in 2023, the World Economic Forum, a Switzerland-based international non-governmental organization, reported an increase in infections such as influenza and respiratory syncytial virus (RSV) since the pandemic. In the USA, by February 2023, influenza alone led to an estimated 24 million illnesses, 260,000 hospitalizations, and 16,000 deaths. Additionally, in 2022, the World Health Organization reported that 10.6 million people worldwide were infected with tuberculosis, resulting in 1.3 million deaths. Consequently, the prevalence of communicable diseases is fueling the growth of the gene editing market.

The global gene editing market is expected to witness growth due to the rising incidence of genetic disorders. Genetic disorders result from abnormalities or mutations in an individual's DNA, either inherited or occurring spontaneously. These disorders can lead to various health issues, either present at birth or developing later in life. Gene editing offers substantial potential in addressing severe genetic diseases such as sickle cell disease, Huntington's disease, B-thalassemia, cystic fibrosis, Alzheimer's, and Parkinson's. For example, the National Library of Medicine (NLM) reported an estimated 6.7 million Americans aged 65 and older living with Alzheimer's dementia (AD) in 2023. The prevalence is projected to increase to 13.8 million by 2060 unless medical breakthroughs intervene. Genetic disorders are on the rise, and the application of gene editing technologies is expected to drive market growth.

Infectious diseases continue to pose a significant threat globally, causing more than 17 million deaths annually, as reported by the World Health Organization (WHO). Public sentiment reflects the growing acceptance of gene editing for the treatment of incurable, hereditary diseases, with 71% of surveyed adults in the US expressing support for its use, according to the AP-NORC survey. Additionally, 67% of Americans endorse gene editing for disease prevention, including conditions such as cancer. This positive perception underscores the potential of gene editing technologies in addressing various health challenges and contributing to market growth.

Major companies are introducing innovative technologies, such as a technique based on special cell-penetrating peptides, which offers advantages over existing methods. In April 2023, Penn Medicine, a prominent US-based multi-hospital health system, discovered that protein fragments used by certain viruses to enter cells could also facilitate the efficient and low-toxicity delivery of CRISPR-Cas gene editing molecules into cells and their DNA-containing nuclei. This breakthrough holds potential for developing advanced cell therapies for diseases such as cancer. The technique is particularly promising for modifying T cells and other patient-derived cells for applications such as CAR T (chimeric antigen receptor T cell) therapy, a specialized immunotherapy for cancer treatment. This new genetic engineering approach promises improvements in speed, efficiency, and reduced cellular toxicity compared to current methods.

The emergence of advanced genome editing techniques stands out as a major trend in the gene editing market. These techniques, characterized by their cost-effectiveness, find applications in diverse fields, including agriculture to enhance the food supply, rectifying specific genetic mutations in the human genome, and preventing the spread of diseases. One notable genome editing technique is CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats), known for its role as molecular scissors that make precise cuts in DNA at specific locations to create space for incorporating new genetic material. CRISPR-Cas9 offers advantages in terms of speed, cost-efficiency, accuracy, and overall effectiveness compared to other existing genome editing methods. Companies such as Crispr Therapeutics (CRSP), Intellia Therapeutics (NTLA), and Editas Medicine are actively investing in CRISPR technology, reflecting the significant impact and potential of this cutting-edge gene editing approach.

In February 2024, Ginkgo Bioworks, a US-based biotechnology company, acquired Patch Biosciences for an undisclosed sum. This acquisition is a significant step in Ginkgo's strategy to strengthen its genetic medicine capabilities, aiming to integrate Patch's AI-driven platform with Ginkgo's current services, including gene therapy, cell therapy, and RNA therapeutics. This move aligns with Ginkgo's broader strategy of expanding its portfolio through acquisitions, particularly of companies focused on molecular medicine and AI-driven drug discovery. Patch Biosciences, a US-based biotechnology company, specializes in gene editing and the development of genetic medicines.

Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gene editing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gene editing market includes revenue earned by zinc-finger nucleases (ZFNs) and homing endonucleases or meganucleases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Editing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene editing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: CRISPR; TALEN; ZFN
• 2) By Application: Animal Genetic Engineering; Plant Genetic Engineering; Cell Line Engineering
• 3) By End Users: Biotechnology; Pharmaceutical; Contract Research Organization
• Subsegments:
• 1) By CRISPR: CRISPR-Cas9; CRISPR-Cas12; CRISPR-Cas13; CRISPR-based Gene Drives
• 2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs; Commercial TALEN Kits
• 3) By ZFN (Zinc Finger Nucleases): Custom ZFNs; Commercial ZFN Kits
• Companies Mentioned: AstraZeneca plc; Thermo Fisher Scientific Inc.; Merck KGaA; GE Healthcare Life Sciences; Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Editing Market Characteristics

3. Gene Editing Market Trends And Strategies

4. Gene Editing Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Gene Editing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gene Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gene Editing Market Growth Rate Analysis
• 5.4. Global Gene Editing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gene Editing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gene Editing Total Addressable Market (TAM)

6. Gene Editing Market Segmentation

• 6.1. Global Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR
• TALEN
• ZFN
• 6.2. Global Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Animal Genetic Engineering
• Plant Genetic Engineering
• Cell Line Engineering
• 6.3. Global Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology
• Pharmaceutical
• Contract Research Organization
• 6.4. Global Gene Editing Market, Sub-Segmentation Of CRISPR, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR-Cas9
• CRISPR-Cas12
• CRISPR-Cas13
• CRISPR-based Gene Drives
• 6.5. Global Gene Editing Market, Sub-Segmentation Of TALEN, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Custom TALENs
• Commercial TALEN Kits
• 6.6. Global Gene Editing Market, Sub-Segmentation Of ZFN, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Custom ZFNs
• Commercial ZFN Kits

7. Gene Editing Market Regional And Country Analysis

• 7.1. Global Gene Editing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gene Editing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Editing Market

• 8.1. Asia-Pacific Gene Editing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Editing Market

• 9.1. China Gene Editing Market Overview
• 9.2. China Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Editing Market

• 10.1. India Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Editing Market

• 11.1. Japan Gene Editing Market Overview
• 11.2. Japan Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Editing Market

• 12.1. Australia Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Editing Market

• 13.1. Indonesia Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Editing Market

• 14.1. South Korea Gene Editing Market Overview
• 14.2. South Korea Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Editing Market

• 15.1. Western Europe Gene Editing Market Overview
• 15.2. Western Europe Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Editing Market

• 16.1. UK Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Editing Market

• 17.1. Germany Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Editing Market

• 18.1. France Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Editing Market

• 19.1. Italy Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Editing Market

• 20.1. Spain Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Editing Market

• 21.1. Eastern Europe Gene Editing Market Overview
• 21.2. Eastern Europe Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Editing Market

• 22.1. Russia Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Editing Market

• 23.1. North America Gene Editing Market Overview
• 23.2. North America Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Editing Market

• 24.1. USA Gene Editing Market Overview
• 24.2. USA Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Editing Market

• 25.1. Canada Gene Editing Market Overview
• 25.2. Canada Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Editing Market

• 26.1. South America Gene Editing Market Overview
• 26.2. South America Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Editing Market

• 27.1. Brazil Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Editing Market

• 28.1. Middle East Gene Editing Market Overview
• 28.2. Middle East Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Editing Market

• 29.1. Africa Gene Editing Market Overview
• 29.2. Africa Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Editing Market Competitive Landscape And Company Profiles

• 30.1. Gene Editing Market Competitive Landscape
• 30.2. Gene Editing Market Company Profiles
  • 30.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE Healthcare Life Sciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gene Editing Market Other Major And Innovative Companies

• 31.1. Lonza Group AG
• 31.2. PerkinElmer Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Qiagen N.V.
• 31.5. CRISPR Therapeutics
• 31.6. Promega Corporation
• 31.7. GenScript USA Inc.
• 31.8. Integrated DNA Technologies Inc.
• 31.9. Intellia Therapeutics Inc.
• 31.10. DNA Script Inc.
• 31.11. Dharmacon Inc.
• 31.12. Precision Biosciences Inc.
• 31.13. Editas Medicine Inc.
• 31.14. OriGene Technologies Inc.
• 31.15. Tecan Group Ltd.

32. Global Gene Editing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Editing Market

34. Recent Developments In The Gene Editing Market

35. Gene Editing Market High Potential Countries, Segments and Strategies

• 35.1 Gene Editing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gene Editing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gene Editing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer